Data-Driven Decision Making

Alessa Therapeutics’ rice-sized implant, Enolen, earns FDA Fast Track, promising a new era for prostate cancer therapy without debilitating side effects.

As privacy laws tighten, a new B2B demand gen model emerges, promising human-verified leads and an end to unreliable third-party data. Here's how.

The diversified company is pivoting to Web3, partnering to transform high-value memorabilia like sports cards and art into tradable digital assets.

As John Partilla steps down after a decade, Jeff Howe takes the helm to guide Screenvision through a pivotal era for cinema advertising and innovation.

A new partnership introduces Utilix, an intelligent software aiming to transform static displays into dynamic, data-driven experiences for retail and beyond.

A new partnership arms independent cancer clinics with advanced AI and data analytics, aiming to improve patient care and ensure their survival.

A breakthrough liquid biopsy shows over 80% accuracy in finding feline lymphoma, offering a non-invasive screening tool for vets and hope for cat owners.

A new partnership aims to bring cutting-edge cancer trials to community clinics, accelerating drug development and expanding patient access to care.

Challenger brand Kodiak partners with analytics giant NIQ, signaling a new data-driven era for competition in the crowded CPG breakfast and snacking aisles.

As the eVTOL race intensifies, Vertical Aerospace appoints key execs from Lotus, Nike, and AB InBev to spearhead its push for certification and scale.

CEO Werner Lanthaler will present FairJourney Bio's data-driven antibody discovery platform at the elite J.P. Morgan conference, signaling major growth.

The UK retail giant is ditching manual spreadsheets for an AI-driven platform to standardize labor and enhance customer experience across 240+ stores.

ALSAC appoints a powerhouse duo, blending deep donor expertise with AI-driven strategy to fuel St. Jude's ambitious $12.9 billion global expansion.

Fox News shattered records in 2025 with 4.5B YouTube views, dominating rivals and signaling a strategic shift from cable supremacy to online dominance.

From AI-powered diagnostics to non-hallucinogenic psychedelics, 2025's discoveries are redefining mental healthcare and offering new hope.

A biotech firm's promising concussion therapy, backed by NFL's Alex Smith, shows an 85% responder rate and now seeks public funding for its final push.

A Boston biotech, armed with $62M and a new name, unveils a plan to build a universal model of the cell, aiming to predict and control its behavior.

Pharma giant Lilly and AI biotech BigHat are teaming up to solve a critical flaw in AI drug discovery, aiming to unlock a new generation of therapies.

A new partnership gives NWS forecasters unprecedented views into weather blind spots, boosting warning capabilities for 130 million Americans.

New data from a major Swedish study reveals SAGA Diagnostics' Pathlight test can predict colorectal cancer recurrence with remarkable accuracy, changing the game.